NEW YORK (GenomeWeb News) – Life Technologies announced today a five-year deal with the US Food and Drug Administration aimed at detecting E. coli and Salmonella.

The agreement comprises three projects, Life Tech said, including the design and validation of new food safety tests for detecting and identifying foodborne pathogens. FDA will provide pathogen strains to Life Tech.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.